ArticleInternational journal of pharmaceutics: X2024

Trends in amorphous solid dispersion drug products approved by the U.S. Food and Drug Administration between 2012 and 2023.

Dana E Moseson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.